secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0000950170-23-047017
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity appoints Dr. Geoffrey Ling to board; Dr. von Eschenbach resigns
--------------------------------------------------------------------------

- Dr. Andrew von Eschenbach resigned as Class I director effective August 31, 2023, not due to any disagreement.
- Dr. Geoffrey Shiu Fei Ling appointed as Class I director to fill the vacancy, effective August 31, 2023.
- Dr. Ling received a stock option for 1,250,000 shares at $0.324 exercise price, vesting over three years.
- Dr. Ling brings >30 years experience in pharma, academia, DARPA, and military; retired U.S. Army colonel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/celu-20230831.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-047017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer